Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Clements

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Infection and Immunity|June 1, 1983
Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccineF A Klipstein, R F Engert, J D Clements, et al.
The Journal of Infectious Diseases|February 1, 1983
Vaccine for enterotoxigenic Escherichia coli based on synthetic heat-stable toxin crossed-linked to the B subunit of heat-labile toxinF A Klipstein, R F Engert, J D Clements, et al.
Nature|August 9, 1990
Channel kinetics determine the time course of NMDA receptor-mediated synaptic currentsR A Lester, J D Clements, G L Westbrook, et al.
Vaccine|July 31, 1998
Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B geneH S Mason, T A Haq, J D Clements, et al.
Infection and Immunity|May 1, 1983
Cloning and molecular characterization of the B subunit of Escherichia coli heat-labile enterotoxinJ D Clements, D C Flint, R F Engert, et al.
Science (New York, N.Y.)|May 5, 1995
Oral immunization with a recombinant bacterial antigen produced in transgenic plantsT A Haq, H S Mason, J D Clements, et al.
Infection and Immunity|March 1, 1984
Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxinF A Klipstein, R F Engert, J D Clements, et al.
Immunology|April 1, 1996
In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in miceK L Bost, R H Holton, T K Cain, et al.
Vaccine|March 4, 2000
Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)C B Morris, E Cheng, A Thanawastien, et al.
Infection and Immunity|January 23, 1999
Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasisL Cárdenas-Freytag, E Cheng, P Mayeux, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Infection and Immunity|June 1, 1983
Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccineF A Klipstein, R F Engert, J D Clements, et al.
The Journal of Infectious Diseases|February 1, 1983
Vaccine for enterotoxigenic Escherichia coli based on synthetic heat-stable toxin crossed-linked to the B subunit of heat-labile toxinF A Klipstein, R F Engert, J D Clements, et al.
Nature|August 9, 1990
Channel kinetics determine the time course of NMDA receptor-mediated synaptic currentsR A Lester, J D Clements, G L Westbrook, et al.
Vaccine|July 31, 1998
Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B geneH S Mason, T A Haq, J D Clements, et al.
Infection and Immunity|May 1, 1983
Cloning and molecular characterization of the B subunit of Escherichia coli heat-labile enterotoxinJ D Clements, D C Flint, R F Engert, et al.
Science (New York, N.Y.)|May 5, 1995
Oral immunization with a recombinant bacterial antigen produced in transgenic plantsT A Haq, H S Mason, J D Clements, et al.
Infection and Immunity|March 1, 1984
Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxinF A Klipstein, R F Engert, J D Clements, et al.
Immunology|April 1, 1996
In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in miceK L Bost, R H Holton, T K Cain, et al.
Vaccine|March 4, 2000
Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)C B Morris, E Cheng, A Thanawastien, et al.
Infection and Immunity|January 23, 1999
Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasisL Cárdenas-Freytag, E Cheng, P Mayeux, et al.
Pageof 11